Genetic Technologies (NSDQ:GENE) settled a lawsuit against Hologic Inc. (NSDQ:HOLX) over one of its gene testing patents, leaving seven other defendants in the suit.

Women’s health firm Hologic was one of nine original defendants in the lawsuit. The settlement involves the licensing of the patent to Hologic in return for undisclosed financial terms, according to a regulatory filing.